1. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68:1178-1182. [PubMed]

2. Kenner M, Menon U, Elliott DG. Multiple sclerosis as a painful disease. Int Rev Neurobiol. 2007;79:303-321. [PubMed]

3. Marchettini P, Formaglio F, Lacerenza M. Pain as a heralding symptom in multiple sclerosis. Neurol Sci. 2006;27(suppl):S294-S296.

4. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology. 1988;38:1830-1834. [PubMed]

5. Pollmann W, Feneberg W, Erasmus LP. Pain in multiple sclerosis—a still underestimated problem: the 1 year prevalence of pain syndromes, significance and quality of care of multiple sclerosis inpatients. Nervenarzt. 2004;75:135-140. [PubMed]

6. Solaro C, Brichetto G, Amato MP, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology. 2004;63:919-921. [PubMed]

7. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008; 65:1191-1194. [PubMed]

8. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2005;51:240-264. [PubMed]

9. Knight YE, Goadsby PJ. Periaqueductal grey matter modulates trigeminovascular input: a role in migraine. Neuroscience. 2001;106:793-800. [PubMed]

10. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal grey matter dysfunction in migraine: cause or the burden of illness? Headache. 2001; 41:629-637. [PubMed]

11. Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995;60:3-38. [PubMed]

12. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-484. [PubMed]

13. Schweinhardt P, Lee M, Tracey I. Imaging pain in patients: is it meaningful? Curr Opin Neurol. 2006;19:392-400. [PubMed]

14. Peyron R, Laurent B, García-Larrea L. Functional imaging of brain responses to pain: a review and meta-analysis. Neurophysiol Clin. 2000; 30:263-288. [PubMed]

15. Chen F-Y, Tao W, Yong-jie Li. Advances in brain imaging of neuropathic pain. Chin Med J. 2008;121:653-657. [PubMed]

16. Kupers RC, Gybels JM, Gjedde A. Positron emission tomography study of a chronic pain patient successfully treated with somatosensory thalamic stimulation. Pain. 2000;87:295-302. [PubMed]

17. Witting N, Kupers RC, Svensson P, Jensen TS. A PET activation study of brush-evoked allodynia in patients with nerve injury pain. Pain. 2006;32: 256-265. [PubMed]

18. Ducreux D, Attal N, Parker F, Bouhassira D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain. 2006;129:963-976. [PubMed]

19. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004; 24:10410-10415. [PubMed]

20. Schmidt-Wilcke T, Leinisch E, Ganbauer S, et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain. 2006;125:89-97. [PubMed]

21. Draganski B, Moser T, Lummel N, et al. Decrease of thalamic gray matter following limb amputation. Neuroimage. 2006;31:951-957. [PubMed]

22.Dworkin RH, Backonja M, Rowbothan MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524-1534. [PubMed]

23. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:1153-1169. [PubMed]

24. Attal N, Cruccu G, Haanpää M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153-1169. [PubMed]

25. Breuer B, Pappagallo M, Knotkova H, et al. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther. 2007;29:2022-2030. [PubMed]

26. Panerai AE, Monza G, Movilia P, et al. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Scand. 1990;82:34-38. [PubMed]

27. Leijon G, Boivie J. Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27-36. [PubMed]

28. Cardenas DD, Warms CA, Turner JA, et al. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain. 2002;96:365-373. [PubMed]

29. Lampl C, Yazdi K, Röper C. Amitriptyline in the prophylaxis of central poststroke pain: preliminary results of 39 patients in a placebo-controlled, long-term study. Stroke. 2002;33:3030-3032. [PubMed]

30. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain (review). Cochrane Database Systemic Rev. 2008;4:1-63. [PubMed]

31. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65:812-819. [PubMed]

32. Rog DJ, Nurmikko TJ, Young CA. Oromucosal for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29:2068-2079. [PubMed]

33. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis: randomised double blind placebo controlled crossover trial. Br Med J. 2004;329:253-261. [PubMed]

34. Karst M, Salim K, Burstein S, et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003;290:1757-1762. [PubMed]

35. Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain. 2004;112:299-306. [PubMed]

36. Eisenberg E, McNicol ED, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD006146.

37. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry. 2007;78:1140-1142. [PubMed]

38. Nandi D, Aziz TZ. Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor. J Clin Neurophysiol. 2004; 21:31-39. [PubMed]

39. Canavero S, Bonicalzi V. Therapeutic extradural cortical stimulation for central and neuropathic pain: a review. Clin J Pain. 2002;18:48-55. [PubMed]

40. Nguyen JP, Lefaucher JP, Le-Guerinel C, et al. Motor cortex stimulation in the treatment of central and neuropathic pain. Arch Med Res. 2000;31:263-265. [PubMed]

41. Katayama Y, Fukaya C, Yamamoto T. Poststroke pain control by chronic motor cortex stimulation: neurological characteristics predicting a favorable response. J Neurosurg. 1998;89:585-591. [PubMed]

42. Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation in patients with thalamic pain. J Neurosurg. 1993;78:393-401. [PubMed]

43. Carroll D, Joint C, Maartens N, Shlugman D, Stein J, Aziz TZ. Motor cortex stimulation for chronic neuropathic pain: a preliminary study of 10 cases. Pain. 2000;84:431-437. [PubMed]

44. Nandi D, Smith H, Owen S, Joint C, Stein JF, Aziz TZ. Peri-ventricular grey stimulation versus motor cortex stimulation for post stroke neuropathic pain. J Clin Neurosci. 2002;9:557-561. [PubMed]